National Clinical Care Commission Act

Bill: 114-hr-1192
Sponsor: Rep. Olson, Pete [R-TX-22]
Introduced: 2015-03-02 in the House
Policy area: Health
Subjects: Advisory bodies
Department of Health and Human Services
Digestive and metabolic diseases
Executive agency funding and structure
Health programs administration and funding
Health promotion and preventive care
Immunology and vaccination
Medical tests and diagnostic methods

Summary:
action_date: 2015-03-02
text: 

National Diabetes Clinical Care Commission Act

 
This bill amends the Public Health Service Act to establish within the Department of Health and Human Services (HHS) the National Diabetes Clinical Care Commission to evaluate and recommend solutions regarding better coordination and leveraging of federal programs that relate to supporting appropriate clinical care for people with pre-diabetes, diabetes, and the chronic diseases and conditions that are complications of or caused by diabetes. 
 
The duties of the Commission include:
 
 
evaluating HHS programs regarding the utilization of preventive health benefits,
 
identifying current activities and critical gaps in federal efforts to support clinicians in providing integrated care,
 
making recommendations regarding the development and coordination of federally funded clinical practice support tools,
 
recommending clinical pathways for new technologies and treatments,
 
evaluating and expanding education and awareness to health care professionals regarding prevention of diabetes, and
 
reviewing and recommending appropriate methods for outreach and dissemination of educational resources.
 
 
The Commission must submit an operating plan to HHS and Congress within 90 days of its first meeting.

action_date: 2016-11-14
text: 

National Clinical Care Commission Act

 
(Sec. 2) This bill amends the Public Health Service Act to establish within the Department of Health and Human Services (HHS) the National Clinical Care Commission to evaluate and recommend solutions regarding better coordination and leveraging of federal programs that relate to supporting clinical care for individuals with a complex metabolic or autoimmune disease, diabetes, or complications caused by such a disease. 
 
The duties of the commission include:
 
 
evaluating HHS programs regarding the utilization of preventive health benefits,
 
identifying current activities and gaps in federal efforts to support clinicians in providing integrated care,
 
making recommendations regarding the development and coordination of federally funded clinical practice support tools,
 
recommending clinical pathways for new technologies and treatments,
 
evaluating and expanding education and awareness activities provided to health care professionals, and
 
reviewing and recommending methods for outreach and dissemination of educational resources.
 
 
The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated at the end of FY2019.


Legislative actions:
action_date: 2016-11-15
text: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
action_date: 2016-11-14
text: The title of the measure was amended. Agreed to without objection.
action_date: 2016-11-14
text: Motion to reconsider laid on the table Agreed to without objection.
action_date: 2016-11-14
text: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6113-6114)
action_date: 2016-11-14
text: Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H6113-6114)
action_date: 2016-11-14
text: DEBATE - The House proceeded with forty minutes of debate on H.R. 1192.
action_date: 2016-11-14
text: Considered under suspension of the rules. (consideration: CR H6113-6115)
action_date: 2016-11-14
text: Mr. Burgess moved to suspend the rules and pass the bill, as amended.
action_date: 2016-11-14
text: Placed on the Union Calendar, Calendar No. 625.
action_date: 2016-11-14
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-801.
action_date: 2016-11-14
text: Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-801.
action_date: 2016-09-21
text: Ordered to be Reported by Voice Vote.
action_date: 2016-09-21
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-09-20
text: Committee Consideration and Mark-up Session Held.
action_date: 2016-09-13
text: Forwarded by Subcommittee to Full Committee by Voice Vote .
action_date: 2016-09-12
text: Subcommittee Consideration and Mark-up Session Held.
action_date: 2015-03-06
text: Referred to the Subcommittee on Health.
action_date: 2015-03-02
text: Referred to the House Committee on Energy and Commerce.
action_date: 2015-03-02
text: Introduced in House
action_date: 2015-03-02
text: Introduced in House